Through strategic licensing, acquisition and independent R&D, Beike Biotechnology has gained a strategic position in the immunotherapy field. Beike has multiple international cutting-edge and innovative immunotherapy technologies and products becoming…

Stephen Hawking is well known as a master of science and also a source of inspiration to millions. He recently opened an account on Weibo, a microblogging social network in…

Beike Biotechnology, the Shenzhen local government, and various medical institutions attended a ceremony in late 2015 to mark their successful combined efforts to provide integrative, personalized cell therapy in 2016….

With the term “stem cells” becoming prevalent in media, the medical world, and day-to-day life, it is becoming increasingly difficult to avoid a conversation about this type of regenerative medicine….

Recently, Beike Biotech celebrated the 10th anniversary of our incorporation by having a corporate retreat to Huizhou, China, a beautiful coastal city just a couple hours Northeast of our headquarters…

On July 15th of 2015, Beike Biotechnology Co., Ltd. alongside leading Chinese hospitals and universities published new research utilizing Wharton’s Jelly derived mesenchymal stem cells as a safe and effective…